Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Klamerus

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Pharmacy|June 1, 1986
Current concepts in clinical therapeutics: congestive heart failureK J Klamerus
Clinical Pharmacy|March 1, 1986
Prolonged continuous infusion of tromethamine in a patient with metabolic acidosisK J Klamerus
American Journal of Hospital Pharmacy|June 1, 1986
Composition of cardioplegic solutions used in nine medical centersK J Klamerus, M A Munger
American Journal of Hospital Pharmacy|September 1, 1988
Effect of clinical pharmacy services on appropriateness of serum digoxin concentration monitoringK J Klamerus, M A Munger
American Journal of Hospital Pharmacy|March 1, 1988
Developing a videocassette program for pharmacy educationK J Klamerus, D J Belsheim
Clinical Pharmacy|August 1, 1987
Controversies in the use of transdermal nitroglycerin systemsF P Zeller, K J Klamerus
American Journal of Hospital Pharmacy|February 1, 1984
Stability of nitroglycerin in intravenous admixturesK J Klamerus, C T Ueda, D W Newton
Antimicrobial Agents and Chemotherapy|May 1, 1988
Effect of cardiopulmonary bypass on vancomycin and netilmicin dispositionK J Klamerus, K A Rodvold, N A Silverman, et al.
Pharmacotherapy|September 1, 1996
Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokineticsK J Klamerus, V D Parker, R L Rudolph, et al.
Journal of Clinical Pharmacology|August 1, 1992
Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metaboliteK J Klamerus, K Maloney, R L Rudolph, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Pharmacy|June 1, 1986
Current concepts in clinical therapeutics: congestive heart failureK J Klamerus
Clinical Pharmacy|March 1, 1986
Prolonged continuous infusion of tromethamine in a patient with metabolic acidosisK J Klamerus
American Journal of Hospital Pharmacy|June 1, 1986
Composition of cardioplegic solutions used in nine medical centersK J Klamerus, M A Munger
American Journal of Hospital Pharmacy|September 1, 1988
Effect of clinical pharmacy services on appropriateness of serum digoxin concentration monitoringK J Klamerus, M A Munger
American Journal of Hospital Pharmacy|March 1, 1988
Developing a videocassette program for pharmacy educationK J Klamerus, D J Belsheim
Clinical Pharmacy|August 1, 1987
Controversies in the use of transdermal nitroglycerin systemsF P Zeller, K J Klamerus
American Journal of Hospital Pharmacy|February 1, 1984
Stability of nitroglycerin in intravenous admixturesK J Klamerus, C T Ueda, D W Newton
Antimicrobial Agents and Chemotherapy|May 1, 1988
Effect of cardiopulmonary bypass on vancomycin and netilmicin dispositionK J Klamerus, K A Rodvold, N A Silverman, et al.
Pharmacotherapy|September 1, 1996
Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokineticsK J Klamerus, V D Parker, R L Rudolph, et al.
Journal of Clinical Pharmacology|August 1, 1992
Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metaboliteK J Klamerus, K Maloney, R L Rudolph, et al.
Pageof 2